| Room 3A | Room 3B | Hall 1B | Hall 1C | Room 11B - Workshop | Room 11C - Workshop | DAY 2 |
| 8:00 |
Event Registration |
|
|
|
|
|
8:00: |
| 8:05: |
|
|
|
|
|
8:05: |
| 8:10: |
|
|
|
|
|
8:10: |
| 8:15: |
|
|
|
|
|
8:15: |
| 8:20: |
|
|
|
|
|
8:20: |
| 8:25: |
|
|
|
|
|
8:25: |
| 8:30: |
|
|
|
|
|
8:30: |
| 8:35: |
|
|
|
|
|
8:35: |
| 8:40: |
|
|
|
|
|
8:40: |
| 8:45: |
|
|
|
|
|
8:45: |
| 8:50: |
|
|
|
|
|
|
8:50: |
| 8:55: |
|
|
|
|
|
8:55: |
| 9:00 |
|
|
|
|
|
|
9:00: |
| 9:05: |
|
|
|
|
|
9:05: |
| 9:10: |
|
|
|
|
|
9:10: |
| 9:15: |
|
|
|
|
|
9:15: |
| 9:20: |
|
|
|
|
|
9:20: |
| 9:25: |
|
|
|
|
|
9:25: |
| 9:30: |
|
|
|
|
|
9:30: |
| 9:35: |
|
|
|
|
|
9:35: |
| 9:40: |
|
|
|
|
|
9:40: |
| 9:45: |
|
|
|
|
|
9:45: |
| 9:50: |
Mind the gap… making a career out of building bridges
09:50 (20 mins)
Laura Ajram, Medicines Discovery Catapult
|
|
|
|
|
|
9:50: |
| 9:55: |
|
|
|
|
|
9:55: |
| 10:00 |
|
|
|
|
|
10:00 |
| 10:05 |
|
|
|
|
|
10:05 |
| 10:10 |
Refreshment Break |
|
|
|
|
|
10:10 |
| 10:15 |
|
|
|
|
|
10:15 |
| 10:20 |
|
|
|
|
|
10:20 |
| 10:25 |
|
|
|
|
|
10:25 |
| 10:30 |
|
|
|
|
|
10:30 |
| 10:35 |
|
|
|
|
|
10:35 |
| 10:40 |
|
|
|
|
|
10:40 |
| 10:45 |
|
|
|
|
|
10:45 |
| 10:50 |
|
|
|
|
|
|
10:50 |
| 10:55 |
10:55 |
| 11:00 |
High-throughput proteomics for gene function prediction, target discovery and precision medicine
11:00 (30 mins)
Markus Ralser, Crick Institute / Dept Biochemistry, Berlin
|
The MRC’s COVID-19 Research Response
11:00 (30 mins)
Jonathan Pearce, UKRI- Medical Research Council
|
High resolution anatomical mapping of gene expression using targeted in situ sequencing
11:00 (30 mins)
Mats Nilsson, SciLifeLab
|
Sir James Black Award Presentation - Anti-CD20, new precision medicines from old targets
11:00 (30 mins)
Daren Austin, GlaxoSmithKline
|
11:00 |
| 11:05 |
11:05 |
| 11:10 |
11:10 |
| 11:15 |
11:15 |
| 11:20 |
11:20 |
| 11:25 |
11:25 |
| 11:30 |
11:30 |
| 11:35 |
11:35 |
| 11:40 |
11:40 |
| 11:45 |
11:45 |
| 11:50 |
|
11:50 |
| 11:55 |
|
11:55 |
| 12:00 |
Automating Image Analysis with Deep Learning to Accelerate Drug Discovery and Increase Mechanistic Insight
12:00 (30 mins)
James Robinson, AstraZeneca
|
Improving diversity in health research and clinical trials
12:00 (30 mins)
Annette Crosse, Egality
|
Live cell compatible super resolution fluorescence microscopy for 3D imaging
12:00 (30 mins)
Ilaria Testa, SciLifeLab Francesca Pennacchietti
|
Tracking GPCR signalling- from the outside in one cell at a time
12:00 (30 mins)
Terence Hébert, McGill University
|
|
12:00 |
| 12:05 |
|
12:05 |
| 12:10 |
|
12:10 |
| 12:15 |
|
12:15 |
| 12:20 |
|
|
12:20 |
| 12:25 |
|
|
12:25 |
| 12:30 |
|
|
12:30 |
| 12:35 |
|
|
12:35 |
| 12:40 |
|
|
12:40 |
| 12:45 |
|
|
12:45 |
| 12:50 |
|
|
12:50 |
| 12:55 |
|
|
12:55 |
| 1:00 |
Refreshment Break |
|
|
|
Equality, Diversity and Inclusion: Awareness to action
13:00 (60 mins)
Lilian Hunt, EDIS, Wellcome Trust
|
|
1:00: |
| 1:05: |
|
|
|
|
1:05: |
| 1:10: |
|
|
|
|
1:10: |
| 1:15: |
|
|
|
|
1:15: |
| 1:20: |
|
|
|
|
1:20: |
| 1:25: |
|
|
|
|
1:25: |
| 1:30: |
|
|
|
|
1:30: |
| 1:35: |
|
|
|
|
1:35: |
| 1:40: |
|
|
|
|
1:40: |
| 1:45: |
|
|
|
|
1:45: |
| 1:50: |
|
|
|
|
1:50: |
| 1:55: |
|
|
|
|
1:55: |
| 2:00 |
|
|
|
|
|
2:00: |
| 2:05: |
|
|
|
|
|
2:05: |
| 2:10: |
|
|
|
|
|
2:10: |
| 2:15: |
|
|
|
|
|
2:15: |
| 2:20: |
|
|
|
|
|
2:20: |
| 2:25: |
|
|
|
|
|
2:25: |
| 2:30: |
Generation of fully human antibodies using high throughput IntelliSelect® Technology Platforms at LifeArc
14:30 (30 mins)
Preeti Bakrania, LifeArc
Alignment of Chemogenomic and Functional Genomic screening for target ID
15:00 (30 mins)
Joanna Redmond, GlaxoSmithKline
|
Democratising Drug Discovery – Widening Access to Expertise and Technologies
14:30 (30 mins)
Peter Simpson, Medicines Discovery Catapult
Open drug discovery on the edge - the COVID Mooonshot's quest for an antiviral pill
15:00 (30 mins)
Frank von Delft, Diamond
|
Chemical Materials Design
14:30 (30 mins)
Ben Slater, Materials Innovation Factory (MIF)
Quantum computing: a new frontier in drug discovery?
15:00 (30 mins)
Sam Genway, Capgemini Engineering
|
Effects of small molecule compounds targeting osteoclasts against RA bone destruction
14:30 (30 mins)
Yanhui Tan, Guangxi Normal University, Guilin, China
Bio-inspired nanoformulations for delivery of advanced therapeutics
15:00 (30 mins)
Rongjun Chen, Imperial College London
|
Learn to Learn
14:30 (90 mins)
Chris Williams, Questae Coaching & Consulting Ltd
|
|
2:30: |
| 2:35: |
|
2:35: |
| 2:40: |
|
2:40: |
| 2:45: |
|
2:45: |
| 2:50: |
|
2:50: |
| 2:55: |
|
2:55: |
| 3:00 |
|
3:00: |
| 3:05: |
|
3:05: |
| 3:10: |
|
3:10: |
| 3:15: |
|
3:15: |
| 3:20: |
|
3:20: |
| 3:25: |
|
3:25: |
| 3:30: |
Comfort Break |
|
|
|
|
3:30: |
| 3:35: |
|
|
|
|
3:35: |
| 3:40: |
A Huntington’s disease embryonic stem cell phenotypic HTS to identify small molecule modulators of mutant HTT
15:40 (30 mins)
Marta Stebbeds, Discovery from Charles River
High-throughput PROTAC synthesis for direct, biological assaying
16:10 (30 mins)
David Battersby, GlaxoSmithKline
|
'Virtual Reality’ – Adding a New Dimension to Drug Design
15:40 (30 mins)
Timur Avkiran
Transforming Research and Medicine through Synthetic Biology
16:10 (30 mins)
Helen Horton, Touchlight
|
A structural biology community assessment of AlphaFold 2 applications
15:40 (30 mins)
Pedro Beltrao, EMBL-EBI
MELLODDY: privacy-preserving federated machine learning across pharma partners
16:10 (30 mins)
Hugo Ceulemans, Janssen Pharmaceutica
|
|
|
3:40: |
| 3:45: |
|
|
3:45: |
| 3:50: |
|
|
3:50: |
| 3:55: |
|
|
3:55: |
| 4:00 |
|
|
|
4:00: |
| 4:05: |
|
|
|
4:05: |
| 4:10: |
|
|
|
4:10: |
| 4:15: |
|
|
|
4:15: |
| 4:20: |
|
|
|
4:20: |
| 4:25: |
|
|
|
4:25: |
| 4:30: |
|
|
|
4:30: |
| 4:35: |
|
|
|
4:35: |
| 4:40: |
|
|
|
|
|
|
4:40: |
| 4:45: |
|
|
|
|
|
4:45: |
| 4:50: |
|
|
|
|
|
4:50: |
| 4:55: |
|
|
|
|
|
4:55: |
| 5:00 |
|
|
|
|
|
|
5:00: |
| 5:05: |
|
|
|
|
|
|
5:05: |
| 5:10: |
|
|
|
|
|
|
5:10: |
| 5:15: |
|
|
|
|
|
|
5:15: |
| 5:20: |
|
|
|
|
|
|
5:20: |
| 5:25: |
|
|
|
|
|
|
5:25: |
| 5:30: |
|
|
|
|
|
|
5:30: |
| 5:35: |
|
|
|
|
|
|
5:35: |
| 5:40: |
|
|
|
|
|
|
5:40: |
| 5:45: |
|
|
|
|
|
|
5:45: |
| 5:50: |
|
|
|
|
|
|
5:50: |
| 5:55: |
|
|
|
|
|
|
5:55: |
| 6:00 |
|
|
|
|
|
|
6:00: |
| 6:05: |
|
|
|
|
|
|
6:05: |
| 6:10: |
|
|
|
|
|
|
6:10: |
| 6:15: |
|
|
|
|
|
|
6:15: |
| 6:20: |
|
|
|
|
|
|
6:20: |
| 6:25: |
|
|
|
|
|
|
6:25: |
| 6:30: |
|
|
|
|
|
|
6:30: |
| 6:35: |
|
|
|
|
|
|
6:35: |
| 6:40: |
|
|
|
|
|
|
6:40: |
| 6:45: |
|
|
|
|
|
|
6:45: |
| 6:50: |
|
|
|
|
|
|
6:50: |
| 6:55: |
|
|
|
|
|
|
6:55: |
| 7:00 |
|
|
|
|
|
|
7:00: |
Print
